「cc」の検索結果
30件：21～25件目を表示
-
TRPV1. A pivotal Phase III clinical trial conducted by Senju (Study Name: 3-02 clinical trial*2 ) successfully met the primary endpoint by demonstrating statistically significant improvement in dry ey...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
TRPV1. A pivotal Phase III clinical trial conducted by Senju (Study Name: 3-02 clinical trial*2 ) successfully met the primary endpoint by demonstrating statistically significant improvement in dry ey...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf -
受付時間 10 時 00 分～18 時 00 分（土、日、祝日を除く） ［報道に関するお問い合わせ先］ 千寿製薬株式会社 広報室 〒541-0048 大阪市中央区瓦町三丁目 1 番 9 号 Mail：cc@senju.co.jp URL：https://www.senju.co.jp 以上
https://www.senju.co.jp/system/files/content_news/2025-04/JPN_20250507.pdf -
benzalkonium chloride (BAC) as a preservative. BAC is widely used in eye drops but it is known to occasionally cause corneal epithelial damage1. Our goal was to develop a formulation that maintains t...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904.pdf -
benzalkonium chloride (BAC) as a preservative. BAC is widely used in eye drops but it is known to occasionally cause corneal epithelial damage1. Our goal was to develop a formulation that maintains t...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904_0.pdf